Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

More personalized and effective treatments for androgenetic alopecia are needed.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

Low-dose oral minoxidil is safe and effective for treating hair loss, with most side effects being mild and reversible.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Finasteride helps hair growth in men but can cause side effects like decreased libido.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Finasteride can cause low platelet count in rare cases.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Hypoxic training didn't change skin features, but skin barrier function is linked to blood lipid levels.

Meibomian glands are highly specialized and differ significantly from other sebaceous glands in structure and function.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride temporarily lowers male rat fertility without affecting libido.

Phytoandrogens from plants may help treat low testosterone naturally.

Human hair follicle stem cells show signs of low oxygen levels, which may be important for hair growth and preventing baldness.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.